• ASCO19 - Bertrand Tombal - EORTC study 1333

    Preliminary results confirm that the addition of bone-protecting agents to Radium-233 (Ra-233) treatment can limit fractures in metastatic castration resistant prostate cancer patients

  • ASCO Annual Meeting 2019
    Categories:

    EORTC abstracts selected at ASCO

  • Collaboration for Cancer Prevention, Research and Support
    Categories:

    EORTC proudly joins Walgreens Boots Alliance in a Transatlantic Charitable Partnership that aims to meet the needs of people living with cancer

  • EORTC Imaging group

    Imaging Group promotes Education and Training through specialist networks

  • European eastern countries
    Categories:

    Challenges in clinical research in Central and Eastern Europe – how can EORTC help?

  • Denis Lacombe at the EU Parliament in Strasbourg
    Categories:

    Affordable health care leaving no one behind: raising awareness and developing actionable policy options

  • cancer in elderly people

    Elderly nursing home residents have fewer cancers – but also fewer referrals and treatments

  • RECIST
    Categories: ,

    RECIST disease assessment is effective for targeted treatment as well as classical chemotherapy